Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
Statin use was associated with increased rates of diabetes in overweight and obese patients.
Among U.S. women, a normally high circulating prolactin concentration is associated with a reduced risk for type 2 diabetes.
Greater variation of fasting plasma glucose over time is associated with an increased risk of developing type 2 diabetes.
Study results indicated that sitagliptin showed greater glycemic efficacy than dapagliflozin treatment.